Caerus Medical

Caerus Medical, founded in 2020 and led by CEO David Vittecoq, operates in the healthcare technology sector with a focus on digital spinal applications. The company was acquired by Gleamer, a specialist in AI for radiology, in February 2025. This strategic acquisition allows Gleamer to expand its capabilities from X-ray, CT, and breast imaging to include MRI analysis.

The firm's core business revolves around developing solutions to optimize patient pathways for spine care. Caerus Medical's primary product, LumbAI, is an AI-powered software designed to analyze lumbar MRI scans. This tool assists radiologists and spine professionals by detecting a wide range of degenerative spine diseases, aiming to accelerate the diagnosis of low back pain and improve post-operative follow-up. The technology is intended to ease the workload of radiologists and enhance diagnostic accuracy. Caerus Medical's business model centers on providing these digital solutions to caregivers and healthcare professionals to create more efficient patient care pathways. The development of its AI solution was supported by its majority strategic shareholder, France Imageries Territoires, a French imaging group.

The company's mission is to bring digital spine solutions to caregivers to streamline patient diagnosis and treatment. The team includes data scientists, engineers, and a medical board comprised of radiologists and professors from various hospitals and clinics. Even after the acquisition by Gleamer, David Vittecoq continues to manage Caerus Medical.

Keywords: medical imaging AI, spine diagnostics, lumbar MRI analysis, radiology software, healthcare technology, digital spine solutions, low back pain diagnosis, patient pathway optimization, degenerative spine disease, medical AI, musculoskeletal MRI, Gleamer, David Vittecoq, LumbAI, France Imageries Territoires, clinical decision support, diagnostic assistance, postoperative follow-up, spine care technology, radiologist tools